N O'Higgins

Objective measurement of breast cancer oestrogen receptor status through digital image analysis.

M. Duffy, E. McDermott, N. O’higgins, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Ets2 transcription factor in normal and neoplastic human breast tissue.

M. Duffy, E. McDermott, N. O’higgins, 2006, European journal of cancer.

Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.

N. Brünner, C. Sweep, E. McDermott, 2005, Oncology reports.

Advances in treatment of breast cancer.

N. O’higgins, N O'Higgins, 1978, Irish medical journal.

Overexpression of the Ets-1 transcription factor in human breast cancer

M. Duffy, E. McDermott, N. O’higgins, 2004, British Journal of Cancer.

Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.

M. Duffy, E. McDermott, N. O’higgins, 1992, Clinical chemistry.

Urokinase plasminogen activator: A prognostic marker in multiple types of cancer

M. Duffy, E. McDermott, N. O’higgins, 1999, Journal of surgical oncology.